Applied Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $144 | $190 | $-667 | $0 |
Gross Profit | 22 | 71 | -1,014 | -118 |
EBITDA | -20,318 | -21,093 | -4,040 | -15,495 |
EBIT | -20,440 | -21,212 | -4,046 | -15,613 |
Net Income | 2,898 | -83,938 | -37,679 | -42,370 |
Net Change In Cash | 144 | 190 | -667 | 0 |
Free Cash Flow | -22,595 | -18,911 | -17,005 | -14,726 |
Cash | 122,197 | 146,484 | 49,898 | 37,457 |
Basic Shares | 152,392 | 125,318 | 84,244 | 90,669 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $9,993 | $10,660 | $0 | $0 |
Gross Profit | 9,640 | -441 | -415 | -380 |
EBITDA | -64,182 | -82,884 | -105,203 | -94,086 |
EBIT | -64,535 | -83,325 | -105,618 | -94,466 |
Net Income | -119,763 | -81,689 | -104,614 | -93,022 |
Net Change In Cash | 9,993 | 10,660 | 0 | 0 |
Cost of Revenue | 38,616 | |||
Free Cash Flow | -55,173 | -78,093 | -90,728 | -78,209 |
Cash | 49,898 | 16,657 | 53,888 | 57,466 |
Basic Shares | 84,244 | 37,825 | 25,598 | 21,966 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.02 |
2024-03-31 | -$0.67 |
2023-12-31 | -$0.34 |
2023-09-30 | -$0.47 |
